These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 29441052)

  • 1. Harnessing the mTOR Pathway for Tuberculosis Treatment.
    Singh P; Subbian S
    Front Microbiol; 2018; 9():70. PubMed ID: 29441052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-Directed Therapeutic Strategies for Tuberculosis.
    Kolloli A; Subbian S
    Front Med (Lausanne); 2017; 4():171. PubMed ID: 29094039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the Role of Everolimus in mTOR Inhibition and Autophagy Promotion as a Potential Host-Directed Therapeutic Target in
    Cerni S; Shafer D; To K; Venketaraman V
    J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30754665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy Induction as a Host-Directed Therapeutic Strategy against
    Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
    Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
    mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy: A new strategy for host-directed therapy of tuberculosis.
    Paik S; Kim JK; Chung C; Jo EK
    Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
    de Wet TJ; Warner DF; Mizrahi V
    Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycobacterial Effects of Everolimus in a Human Granuloma Model.
    Ashley D; Hernandez J; Cao R; To K; Yegiazaryan A; Abrahem R; Nguyen T; Owens J; Lambros M; Subbian S; Venketaraman V
    J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32610643
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimycobacterial and Anti-inflammatory Mechanisms of Baicalin via Induced Autophagy in Macrophages Infected with
    Zhang Q; Sun J; Wang Y; He W; Wang L; Zheng Y; Wu J; Zhang Y; Jiang X
    Front Microbiol; 2017; 8():2142. PubMed ID: 29163427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
    Lee HJ; Ko HJ; Kim SH; Jung YJ
    PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage targeted polymeric curcumin nanoparticles limit intracellular survival of
    Gupta PK; Jahagirdar P; Tripathi D; Devarajan PV; Kulkarni S
    Front Immunol; 2023; 14():1233630. PubMed ID: 37583694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA-Approved Amoxapine Effectively Promotes Macrophage Control of Mycobacteria by Inducing Autophagy.
    Wang J; Sha J; Strong E; Chopra AK; Lee S
    Microbiol Spectr; 2022 Oct; 10(5):e0250922. PubMed ID: 36129262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation.
    Ahmed S; Raqib R; Guðmundsson GH; Bergman P; Agerberth B; Rekha RS
    Antibiotics (Basel); 2020 Jan; 9(1):. PubMed ID: 31936156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Drug-Sensitive and -Resistant Strains of Mycobacterium tuberculosis by Inhibition of Src Family Kinases Lowers Disease Burden and Pathology.
    Chandra P; Rajmani RS; Verma G; Bhavesh NS; Kumar D
    mSphere; 2016; 1(2):. PubMed ID: 27303736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berbamine promotes macrophage autophagy to clear
    Zhang S; Zhou X; Ou M; Fu X; Lin Q; Tao X; Wang Z; Liu A; Li G; Xu Y; Zhang G
    mBio; 2023 Aug; 14(4):e0027223. PubMed ID: 37382506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-Directed Therapies for Tuberculosis.
    Jeong EK; Lee HJ; Jung YJ
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus.
    Zhao L; Fan K; Sun X; Li W; Qin F; Shi L; Gao F; Zheng C
    Front Immunol; 2023; 14():1305325. PubMed ID: 38259491
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.